# Chinalife Tech-Innovation Fund

> Chinalife Tech-Innovation Fund is a VC fund backing Energy, Mining and Medical. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 3
- Last investment: May 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/china-life-asset-management-company/

Chinalife Tech-Innovation Fund is a money management firm. It was established in 2007, the firm invests in infrastructure construction, culture, media, bio-medicine, real estate and finance sector including real estate and private equity. It is subordinated to China Life Insurance (Group) Company.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Energy | 1 | 33% |
| Mining | 1 | 33% |
| Medical | 1 | 33% |
| Mineral | 1 | 33% |
| Biopharma | 1 | 33% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Private Equity | 1 | 33% |
| Post-IPO Equity | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Pangang Group Vanadium Titanium & Resources | Pangang Group Vanadium Titanium & Resources is a supplier of vanadium and titanium products. Their products use in industries such as steel, non-ferrous metallurgy, chemicals, and energy and sold to markets |  | Post-IPO Equity | May 26, 2025 |  |
| CNNC Huineng | CNNC Huineng is a platform for the development, construction, operation of non-nuclear new energy industries. | $109M | Private Equity | Nov 20, 2024 |  |
| Huisheng Biopharmaceutical | Huisheng Bio is a diabetes and complication treatment solution provider, focusing on the field of diabetes and complication treatment. | $74.8M | Series A | Jun 01, 2022 |  |

3 of 3 investments shown.

## Co-investors
- [ABC International](https://shizune.co/investors/profile/abc-international) — VC Fund, 1 deal together
- Anyang Iron & Steel Group — VC Fund, 1 deal together
- [Bocom Investment](https://shizune.co/investors/profile/bocom-investment) — VC Fund, 1 deal together
- CCB Investments — VC Fund, 1 deal together
- China National Nuclear Power — VC Fund, 1 deal together
- [Ginkgo Capital](https://shizune.co/investors/profile/ginkgo-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Chinalife Tech-Innovation Fund invest in?

Chinalife Tech-Innovation Fund invests primarily in Energy, Mining and Medical startups, most often at Series A and Private Equity stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Chinalife Tech-Innovation Fund last invest?

The most recent investment recorded for Chinalife Tech-Innovation Fund closed in May 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co